Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move
These companies are benefiting from a tidal wave of demand for new weight-loss drugs.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for HIMS skewed bearish (3 of 4 scored calls).
| Insider | Role | Date | Type | Value |
|---|---|---|---|---|
| WELLS DAVID B | Director | May 26 '26 | Buy | 1172974.0 |
| Okupe Oluyemi | Chief Financial … | May 18 '26 | Option Exercise | 39830.0 |
| Okupe Oluyemi | Chief Financial … | May 18 '26 | Sale | 187916.0 |
| Boughton Soleil | Chief Legal … | Apr 20 '26 | Sale | 283890.0 |
| Okupe Oluyemi | Chief Financial … | Apr 20 '26 | Option Exercise | 108531.0 |
| Okupe Oluyemi | Chief Financial … | Apr 20 '26 | Sale | 588615.0 |
| Okupe Oluyemi | Chief Financial … | Apr 17 '26 | Option Exercise | 30982.0 |
| Okupe Oluyemi | Chief Financial … | Apr 16 '26 | Sale | 956147.0 |
| Okupe Oluyemi | Chief Financial … | Apr 17 '26 | Sale | 501158.0 |
| Boughton Soleil | Officer | Apr 20 '26 | Proposed Sale | 283890.0 |
Source: FinViz — Data may be delayed
AI-curated news influencing HIMS price, sentiment, and trend
These companies are benefiting from a tidal wave of demand for new weight-loss drugs.
Multi-Provider AI Analysis